Suppr超能文献

使用基于体外灌注的生物反应器进行大鼠后肢的采购与去细胞化以用于血管化复合异体移植

Procurement and Decellularization of Rat Hindlimbs using an Ex Vivo Perfusion-based Bioreactor for Vascularized Composite Allotransplantation.

作者信息

Adil Aisha, Karoubi Golnaz, Haykal Siba

机构信息

Latner Thoracic Research Surgical Laboratories, University Health Network, Toronto General Hospital; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto.

Latner Thoracic Research Surgical Laboratories, University Health Network, Toronto General Hospital; Institute of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto.

出版信息

J Vis Exp. 2022 Jun 9(184). doi: 10.3791/64069.

Abstract

Patients with severe traumatic injuries and tissue loss require complex surgical reconstruction. Vascularized composite allotransplantation (VCA) is an evolving reconstructive avenue for transferring multiple tissues as a composite subunit. Despite the promising nature of VCA, the long-term immunosuppressive requirements are a significant limitation due to the increased risk of malignancies, end-organ toxicity, and opportunistic infections. Tissue engineering of acellular composite scaffolds is a potential alternative in reducing the need for immunosuppression. Herein, the procurement of a rat hindlimb and its subsequent decellularization using sodium dodecyl sulfate (SDS) is described. The procurement strategy presented is based upon the common femoral artery. A machine perfusion-based bioreactor system was constructed and used for ex vivo decellularization of the hindlimb. Successful perfusion decellularization was performed, resulting in a white translucent-like appearance of the hindlimb. An intact, perfusable, vascular network throughout the hindlimb was observed. Histological analyses showed the removal of nuclear contents and the preservation of tissue architecture across all tissue compartments.

摘要

患有严重创伤性损伤和组织缺损的患者需要进行复杂的外科重建。血管化复合组织异体移植(VCA)是一种不断发展的重建途径,可将多种组织作为一个复合亚单位进行移植。尽管VCA前景广阔,但由于恶性肿瘤、终末器官毒性和机会性感染的风险增加,长期免疫抑制需求是一个重大限制。无细胞复合支架的组织工程是减少免疫抑制需求的一种潜在替代方法。本文描述了大鼠后肢的获取及其随后使用十二烷基硫酸钠(SDS)进行的去细胞化过程。所提出的获取策略基于股总动脉。构建了基于机器灌注的生物反应器系统,并用于后肢的体外去细胞化。成功进行了灌注去细胞化,后肢呈现出白色半透明样外观。观察到整个后肢有完整、可灌注的血管网络。组织学分析表明,所有组织隔室中的细胞核内容物均被去除,组织结构得以保留。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验